Increased expression of RANTES, CCR3 and CCR5 in the lesional skin of patients with atopic eczema

被引:26
作者
Kato, Y
Pawankar, R
Kimura, Y
Kawana, S
机构
[1] Nippon Med Coll, Dept Otolaryngol, Bunkyo Ku, Tokyo 1138603, Japan
[2] Nippon Med Coll, Dept Dermatol, Tokyo 1138603, Japan
关键词
atopic eczema; RANTES; CCR3; CCR5; eosinophil; T cell; mite allergen; patch test;
D O I
10.1159/000091170
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Atopic eczema (AE) is a relapsing inflammatory disease based on IgE sensitization and characterized by peripheral blood eosinophilia and eosinophil infi ltration into the lesional skin. In the patch test reaction of AE by allergens, an increased infi ltration of activated eosinophils has been demonstrated peaking at 24-48 h. Regulated on activation normal T cell expressed and secreted (RANTES/CCL5) is a chemokine that induces eosinophil migration, and CCR3 and CCR5 are the receptors of RANTES. Objective: In order to further clarify the pathomechanisms of eosinophil infi ltration in ongoing chronic inflammation in the skin of patients with AE and its relation to disease severity, we examined the expression of RANTES and its receptors CCR3 and CCR5 in challenged and unchallenged lesional skin of AE. Methods: We examined the number of RANTES+ cells, CCR3+ cells, CCR5+ cells, activated (EG2+) eosinophils and CD3+ T cells in normal skin of healthy volunteers, and in challenged lesional skin (24 h after mite patch test) as well as unchallenged lesional skin of AE patients by immunohistochemistry. The cellular source of RANTES, CCR3 and CCR5 was analyzed by double immunohistochemistry using specific antibodies to RANTES, CCR3 or CCR5, and antibodies to ECP (EG2) or CD3. Results: The numbers of RANTES+ cells, CCR3+ cells, CCR5+ cells, EG2+ cells and CD3+ cells were all significantly increased in challenged (mite patch-tested) lesional skin of AE patients as compared to those in unchallenged lesional skin and normal skin. The numbers of these cells in unchallenged lesional skin were greater than those in normal skin. The number of EG2+ cells in the unchallenged lesional skin correlated with both the peripheral blood eosinophil count and the SCORAD index. The number of EG2+ cells in challenged lesional skin correlated with the number of CCR5+ cells. Activated eosinophils and T cells expressed RANTES and various proportions of these cells were CCR3+ and CCR5+ in both challenged and unchallenged lesional skin. Conclusion: Taken together, these results suggest that RANTES as well as its receptors CCR3 and CCR5 may play important roles in the orchestration of eosinophil infiltration in ongoing chronic inflammation in AE, and also reflect the severity of disease. Copyright (C) 2006 S. Karger AG, Basel.
引用
收藏
页码:245 / 257
页数:13
相关论文
共 46 条
[1]   Recent highlights in the pathophysiology of atopic eczema [J].
Allam, JP ;
Bieber, T ;
Novak, N .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2005, 136 (02) :191-197
[2]  
[Anonymous], ACTA DERM VENERE S92, DOI [10.2340/00015555924447, DOI 10.2340/00015555924447]
[3]  
Beck LA, 1997, J IMMUNOL, V159, P2962
[4]   Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s [J].
Bonecchi, R ;
Bianchi, G ;
Bordignon, PP ;
D'Ambrosio, D ;
Lang, R ;
Borsatti, A ;
Sozzani, S ;
Allavena, P ;
Gray, PA ;
Mantovani, A ;
Sinigaglia, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (01) :129-134
[5]  
Borchers MT, 2002, J LEUKOCYTE BIOL, V71, P1033
[6]   Urine, eosinophil protein X (EPX) is an in vitro parameter of inflammation in atopic dermatitis of the adult age [J].
Breuer, K ;
Kapp, A ;
Werfel, T .
ALLERGY, 2001, 56 (08) :780-784
[7]   Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB) [J].
Breuer, K ;
Wittmann, M ;
Bösche, B ;
Kapp, A ;
Werfel, T .
ALLERGY, 2000, 55 (06) :551-555
[8]   THE INVOLVEMENT OF EOSINOPHILS IN THE PATCH TEST REACTION TO AEROALLERGENS IN ATOPIC-DERMATITIS - ITS RELEVANCE FOR THE PATHOGENESIS OF ATOPIC-DERMATITIS [J].
BRUIJNZEEL, PLB ;
KUIJPER, PHM ;
KAPP, A ;
WARRINGA, RAJ ;
BETZ, S ;
BRUIJNZEELKOOMEN, CAFM .
CLINICAL AND EXPERIMENTAL ALLERGY, 1993, 23 (02) :97-109
[9]  
BRUIJNZEELKOOME.C, 1988, BRIT J DERMATOL, V118, P229
[10]  
Cox HE, 1998, BRIT J DERMATOL, V138, P182